Volume | 416,411 |
|
|||||
News | - | ||||||
Day High | 209.28 | Low High |
|||||
Day Low | 205.26 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Teleflex Inc | TFX | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
208.67 | 205.26 | 209.28 | 206.56 | 207.38 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
9,473 | 416,411 | $ 206.87 | $ 86,143,268 | - | 177.633 - 276.43 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 55,946 | $ 206.56 | USD |
Teleflex Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
9.72B | 47.06M | - | 2.98B | 356.33M | 7.57 | 27.27 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Teleflex News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TFX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 215.27 | 216.715 | 205.26 | 210.36 | 200,355 | -8.71 | -4.05% |
1 Month | 225.00 | 227.65 | 205.26 | 217.01 | 254,931 | -18.44 | -8.20% |
3 Months | 246.97 | 256.85 | 205.26 | 228.18 | 265,993 | -40.41 | -16.36% |
6 Months | 191.42 | 257.85 | 177.633 | 225.40 | 273,058 | 15.14 | 7.91% |
1 Year | 258.76 | 276.43 | 177.633 | 229.25 | 281,982 | -52.20 | -20.17% |
3 Years | 430.23 | 449.375 | 177.633 | 276.69 | 327,913 | -223.67 | -51.99% |
5 Years | 275.30 | 449.375 | 177.633 | 301.29 | 294,188 | -68.74 | -24.97% |
Teleflex Description
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (25% of 2021 sales), interventional (15%), anesthesia (14%), surgical (13%), interventional urology (12%), original-equipment manufacturing (9%), and all other (12%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder. |